Incorporated in 1911, International Business Machines, or IBM, is one of the oldest technology companies in the world... Show more
International Business Machines Corporation has spent several years repositioning from a legacy hardware and services firm into a software-led, hybrid-cloud and AI platform company. Software has climbed to about 45% of revenue, up from roughly 25% in 2018, and now drives the majority of segment pre-tax income. That structural shift matters because subscription and consumption-based software carries higher margins, better cash conversion, and more recurring revenue than hardware or project-based services.
IBM's competitive edge rests on four software pillars — hybrid cloud (anchored by Red Hat and OpenShift), automation (including HashiCorp and Apptio), transaction processing (its mainframe-linked software moat), and data (including Confluent and watsonx). Red Hat has grown to a roughly $8 billion run-rate business, while OpenShift has become a roughly $2 billion annual recurring revenue (ARR, the value of recurring subscription contracts) franchise growing near 30%. This portfolio allows IBM to monetize enterprise AI workloads across on-premise, private, and public cloud environments — a differentiated position versus hyperscaler-only approaches.
The main structural risk is concentration: transaction processing and the IBM Z mainframe cycle can be lumpy, and consulting revenue growth has remained subdued even as generative-AI signings rise. Management's ability to convert AI demand into durable, high-margin revenue — rather than one-off projects — is central to the medium-term outlook.
The most immediate catalyst is IBM's third-quarter earnings report, expected in late October 2026. Management has guided to full-year 2026 constant-currency revenue growth of 4% to 5% and roughly $1 billion of free cash flow growth, with software growth of 6% to 8%. Whether the company confirms that slipped second-quarter deals are converting — management said about a third had already closed within weeks of the quarter's end — will shape near-term investor sentiment.
Beyond earnings, the key catalysts include the pace of mainframe (z17) program-to-program activity, which management indicated was running above 120% of the prior cycle, and the integration of the Confluent acquisition, which closed in early 2026 and adds data-streaming capabilities central to AI pipelines. Progress on the quantum roadmap and new generative-AI product releases under watsonx could also move the narrative.
On the analyst front, expectations have become more mixed. Bank of America (BofA) retains a Buy rating with a $280 price target, while J.P. Morgan maintains an Overweight stance around a $250 target. Truist initiated coverage at Hold with a $240 target, and Morgan Stanley carries a Hold with a lower target. Consensus ratings remain broadly constructive — roughly a "Moderate Buy" to "Buy" — but the direction of recent price-target revisions has been downward, reflecting reduced 2026 growth assumptions.
IBM's trajectory is closely tied to enterprise information-technology (IT) spending cycles, which in turn respond to interest rates and economic confidence. Higher-for-longer rates can delay large, capex-heavy mainframe and infrastructure purchases, while softer budgets can stretch consulting sales cycles. Currency is another lever: a strengthening U.S. dollar was cited as a headwind to reported revenue growth in the second half of 2026.
The broader technology environment is a double-edged sword. Enterprise AI adoption is a genuine demand driver for hybrid cloud, data management, and automation software — areas where IBM competes. At the same time, near-term client budgets have shifted toward servers, storage, and memory to secure supply-constrained AI hardware, which temporarily crowded out IBM's software and mainframe-linked deals. Regulatory developments around AI and data governance could also influence demand for IBM's enterprise-trust and data-orchestration offerings.
Tickeron's Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, exchange-traded fund (ETF), or other asset may move bullish, bearish, or sideways over the next week or month. Designed to surface developing trends, the tool assists users in evaluating possible breakouts or reversals and exploring predictions across a wide range of tradable instruments. It includes searchable prediction categories, historical context, and alert-oriented functionality to support timely decision-making. For investors tracking IBM's evolving software and AI narrative, tools like the Trend Prediction Engine can offer an additional, data-driven perspective on near-term directional signals.
Looking toward 2026 and beyond, IBM's story is defined by several structural drivers. The first is mix evolution: as software grows as a share of revenue, margins and free-cash-flow conversion should remain resilient. Consensus estimates suggest IBM converts a meaningfully higher portion of revenue into free cash flow than many technology peers, a characteristic that supports the investment case for a higher-quality earnings stream.
Second is the AI and hybrid-cloud opportunity. OpenShift, Red Hat, watsonx, and the Confluent data-streaming platform position IBM to capture enterprise AI deployment as workloads move from experimentation to production. A generative-AI book of business that has grown rapidly and a consulting backlog increasingly weighted toward AI point to gradual, not immediate, revenue conversion.
Third is quantum computing. IBM has committed significant investment toward a fault-tolerant quantum system near the end of the decade. This remains long-dated and uncertain, but it represents optionality that could reframe IBM's valuation if technical milestones are met.
The principal risks are execution-related: whether deferred contracts convert at healthy economics, whether organic (non-acquisition) software growth reaccelerates, and whether AI spending displaces rather than complements IBM's core businesses. Capital allocation — balancing acquisitions like Confluent and HashiCorp against shareholder returns and debt management — will also influence the long-term outlook. Analysts' average price targets currently imply modest upside, but the wide dispersion in estimates reflects genuine uncertainty about the timing and durability of the software-led acceleration.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, IBM has been loosely correlated with DXC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if IBM jumps, then DXC could also see price increases.
| Ticker / NAME | Correlation To IBM | 1D Price Change % | ||
|---|---|---|---|---|
| IBM | 100% | +0.58% | ||
| DXC - IBM | 51% Loosely correlated | +0.06% | ||
| GIB - IBM | 50% Loosely correlated | -0.21% | ||
| CTSH - IBM | 47% Loosely correlated | -4.31% | ||
| ACN - IBM | 46% Loosely correlated | -3.62% | ||
| HCKT - IBM | 46% Loosely correlated | -2.85% | ||
More | ||||
| Ticker / NAME | Correlation To IBM | 1D Price Change % |
|---|---|---|
| IBM | 100% | +0.58% |
| Technology Services category (397 stocks) | 23% Poorly correlated | -0.85% |
a manufacturer of various computer products through the use of advanced information technology
Industry InformationTechnologyServices
IBM moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend. In 21 of 31 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 68%.
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on IBM as a result. In 48 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.
The Moving Average Convergence Divergence (MACD) for IBM just turned positive on October 09, 2026. Looking at past instances where IBM's MACD turned positive, the stock continued to rise in 17 of 37 cases over the following month. The odds of a continued upward trend are 46%.
The 10-day moving average for IBM crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.
Following a +0.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBM advanced for three days, in 248 of 375 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
IBM broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IBM entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 29 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 40 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. IBM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.934) is normal, around the industry mean (2.658). P/E Ratio (22.126) is within average values for comparable stocks, (16.591). Projected Growth (PEG Ratio) (2.087) is also within normal values, averaging (2.284). Dividend Yield (0.027) settles around the average of (0.119) among similar stocks. P/S Ratio (3.271) is also within normal values, averaging (139.965).
The Tickeron PE Growth Rating for this company is 81 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.